IPO Timeline
Broker Results (T-2)
2021-01-13
Some brokers release in afternoon
Grey Market (T-1)
2021-01-14
Afternoon
HKEX Allotment (T-1)
2021-01-14
Evening
Registrar Allotment (T-1)
2021-01-14
Evening
Listing Day (T)
2021-01-15
First day of trading
Company Overview
| Stock Name | 現代中藥集團有限公司 |
|---|---|
| Stock Code | 01643 |
| Company Full Name | 現代中藥集團有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事生產中成藥。 |
| Listing Date | 2021-01-15 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國河北省承德市津圍公路88號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.cdysjdyy.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 1.18 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 53,100,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 1.26 |
|---|---|
| First Day Open | HK$ 1.17 |
| First Day Change | 6.78% |
| First Day Volume | 83169000.0 |
| First Day Turnover | 103949000.0 |
Use of Proceeds
| Use of Proceeds | 1、約44.0%或51.7百萬港元將用于提高及擴大產能，進一步生產我們的主要膠囊處方藥； 2、約16.8%或19.7百萬港元將用于擴大我們華南及華東的分銷網絡； 3、約10.2%或12.0百萬港元將用于提高品牌知名度，方法為媒體營銷及推廣； 4、約19.9%或23.4百萬港元將用于進一步加大研發力度、采購質量管理設備及 擴大產品組合，長遠而言為業務增值； 5、約3.4%或4.0百萬港元將用于升級IT系統； 6、約5.7%或6.6百萬港元將撥作營運資金及用作其他一般公司用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
东吴证券国际融资有限公司 CE BBG379
Overall Coordinators (2)
东吴证券国际经纪有限公司 CE AYA587
CS Wealth Securities Limited CE AAD244
Joint Bookrunners (8)
东吴证券国际经纪有限公司 CE AYA587
CS Wealth Securities Limited CE AAD244
浦银国际融资有限公司 CE BFZ375
交银国际证券有限公司 CE APJ121
越秀证券有限公司 CE ABQ722
山证国际证券有限公司 CE BEM330
申万宏源证券（香港）有限公司 CE AAC927
千里硕证券有限公司
Joint Lead Managers (13)
东吴证券国际经纪有限公司 CE AYA587
CS Wealth Securities Limited CE AAD244
浦银国际融资有限公司 CE BFZ375
交银国际证券有限公司 CE APJ121
越秀证券有限公司 CE ABQ722
山证国际证券有限公司 CE BEM330
申万宏源证券（香港）有限公司 CE AAC927
千里硕证券有限公司
ZMF Asset Management Limited CE AWF641
DL SECURITIES (HK) LIMITED CE AZN279
方德证券有限公司 CE BGP713
中国北方证券集团有限公司 CE ATM582
MASTERLINK SECURITIES (HONG KONG) CORPORATION LIMITED CE ACS304
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 孫新磊 |
|---|---|
| Company Secretary | 謝婉婷,賈艷茹 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 現代生物科技集團控股有限公司(75%) |
|---|
IPO Timeline
